EMA
approval
· 2019-03-01
CHMP recommends authorisation of new treatment for phenylketonuria, a rare inherited metabolic disease
Summary
The CHMP recommends authorisation of a new treatment for phenylketonuria, a rare inherited metabolic disease.
Upgrade for the full analysis, importance score, and drug timeline.